Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:foundedYear |
2001
|
| gptkbp:founder |
gptkb:Raymond_Hamers
|
| gptkbp:fullName |
Ablynx NV
|
| gptkbp:headquartersLocation |
gptkb:Ghent,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
ABLX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
nanobody therapeutics
|
| gptkbp:stockExchange |
gptkb:Euronext_Brussels
|
| gptkbp:stockSymbol |
gptkb:ABLX
|
| gptkbp:website |
https://www.ablynx.com/
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
7
|